A metabolite of piribedil
Related Products
Parent Compound(s)
30321Piribedil
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Piribedil N-oxide

Item No. 36328

Technical Information
Formal Name
2-[4-(1,3-benzodioxol-5-ylmethyl)-4-oxido-1-piperazinyl]-pyrimidine
CAS Number
53954-71-5
Molecular Formula
C16H18N4O3
Formula Weight
Purity
≥90%
A solid
DMF: slightlyDMSO: slightlyEthanol: 5 mg/mlPBS (pH 7.2): 1 mg/ml
λmax
240 nm
SMILES
[O-][N+]1(CCN(CC1)C2=NC=CC=N2)CC3=CC=C4OCOC4=C3
InChi Code
InChI=1S/C16H18N4O3/c21-20(11-13-2-3-14-15(10-13)23-12-22-14)8-6-19(7-9-20)16-17-4-1-5-18-16/h1-5,10H,6-9,11-12H2
InChi Key
UOCNNJVJUXZOHP-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Piribedil N-oxide is a metabolite of the dopamine receptor agonist piribedil (Item No. 30321).1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Sarati, S., Guiso, G., Garattini, S., et alKinetics of piribedil and effects on dopamine metabolism: Hepatic biotransformation is not a determinant of its dopaminergic action in rats. Psychopharmacol. (Berl) 105(4), 541-545 (1991).